The global diabetic nephropathy market is anticipated to grow at a considerable CAGR of 5.3% during the forecast period (2021-2027). As per CDC, diabetes is the major reason for end-stage renal disease (ESRD). Around 26 million people in the US had diabetes in 2011, and amongst them, more than 200,000 people had end-stage renal disease due to diabetes. At this stage, a kidney transplant is the only treatment that can be implemented. However, medications, kidney dialysis, and acupuncture are other possible treatments. Medication is the primary treatment given to the patients. Diuretics, angiotensin-converting enzyme inhibitors, antioxidant inflammation modulator, angiotensin receptor blockers, renin inhibitors, calcium channel blockers, monocyte chemoattractant proteins inhibitor, and G protein-coupled receptors are the prominent medications given to patients of diabetic nephropathy.
Browse the full report description of "Global Diabetic Nephropathy Market Size, Share & Trends Analysis Report by Indication (Diabetes Type-1, and Diabetes Type-2), By Diagnosis (Urine Test, Imaging Test, Blood Test, Renal Function Test, and Renal Biopsy), and By Treatment (Medications, Kidney Dialysis, Kidney Transplant) Forecast Period 2021-2027" at https://www.omrglobal.com/industry-reports/diabetic-nephropathy-market
According to the International Journal of Advances in Medicine, around 79.4 million people will have diabetes in 2030, and by the time they get diagnosed they have been affected with some other nephropathy disease. This had given a clear vision of the growing diabetic nephropathy market in the future.
Market Coverage
o By Indication
o By Diagnosis
o By Treatment
o North America
o Europe
o Asia-Pacific
o Rest of the World
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Diabetic Nephropathy Market Report Segment
By Indication
By Diagnosis
By Treatment
Global Diabetic Nephropathy Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/diabetic-nephropathy-market